Clinical Evaluation of a Novel Textile Radiation Protection Device
Evaluation of Novel Woven Fabric Radiation Protection Gear for Head and Neck Regions for Interventional Radiology Personnel
調査の概要
詳細な説明
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Michael Kassin, MD
- 電話番号:770-712-6913
- メール:michael.t.kassin@emory.edu
研究場所
-
-
Georgia
-
Atlanta、Georgia、アメリカ、30322
- Emory University Hospital
-
コンタクト:
- Michael U Kassin, MD
- 電話番号:770-712-6913
- メール:michael.t.kassin@emory.edu
-
Atlanta、Georgia、アメリカ、30308
- Emory University Hospital Midtown
-
コンタクト:
- Michael UH Kassin, MD
- 電話番号:770-712-6913
- メール:michael.t.kassin@emory.edu
-
コンタクト:
- Emory UH Midtown
-
Atlanta、Georgia、アメリカ、30308
- Winship Cancer Institute
-
コンタクト:
- Michael UH Kassin, MD
- 電話番号:770-712-6913
- メール:michael.t.kassin@emory.edu
-
コンタクト:
- Emory UH Midtown
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Age ≥18 years.
- Employed or regularly working in the IR department at the study site.
- Routinely present in fluoroscopy-guided procedures (e.g., IR attending, IR trainee, technologist, IR nurse, anesthesia provider).
- Scheduled to work in procedure rooms equipped with Texray garments and dosimetry systems during the study period.
- Willing and able to provide informed consent.
- Willing to wear Texray PPE and/or standard PPE with dosimeters as specified by the study protocol.
Exclusion Criteria:
- Age <18 years.
- Not regularly present in IR suites during fluoroscopy-based procedures.
- Known pregnancy at the time of enrollment.
- Presence of a musculoskeletal or dermatologic condition that, in the opinion of the investigator or the participant, would prevent safe use of the Texray garments (e.g., inability to tolerate additional weight or fabric contact).
- Decline to participate or are unable to provide informed consent.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:非ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Group A: Standard Personal Protective Equipment (PPE) only then Texray PPE
Participants in Group A will wear their usual radiation personal protection equipment (PPE) during procedures for the first 4 weeks.
After completing a brief orientation and fitting session for the Texray personal protective equipment (PPE), they will wear the HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures for the following 4 weeks.
|
Standard PPE (Baseline Phase): Participants wear their usual radiation protection equipment, including standard lead aprons and thyroid collars (and any head coverings they already use). Personal dosimeters are placed at predefined anatomical regions mimicking Texray coverage (e.g., forehead, temples, anterior/lateral thyroid) over standard PPE. These readings provide baseline scatter radiation exposure under current clinical conditions. Texray PPE (Intervention Phase): During the intervention phase, participants wear HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures. Each garment includes internal and external dosimeter pockets at key anatomical sites to enable paired measurements beneath and outside the shield. These data support calculation of percent dose reduction and attenuation at specific sites. |
|
実験的:Texray PPE then Standard PPE only
Participants in Group B will complete a brief orientation and fitting session for the Texray personal protective equipment (PPE) and will wear the HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures for the first 4 weeks.
They will then switch to wearing their usual radiation PPE during procedures for the following 4 weeks.
|
Standard PPE (Baseline Phase): Participants wear their usual radiation protection equipment, including standard lead aprons and thyroid collars (and any head coverings they already use). Personal dosimeters are placed at predefined anatomical regions mimicking Texray coverage (e.g., forehead, temples, anterior/lateral thyroid) over standard PPE. These readings provide baseline scatter radiation exposure under current clinical conditions. Texray PPE (Intervention Phase): During the intervention phase, participants wear HeadPeace (non-lead head protector) and MindPeace (non-lead thyroid and face protector) during procedures. Each garment includes internal and external dosimeter pockets at key anatomical sites to enable paired measurements beneath and outside the shield. These data support calculation of percent dose reduction and attenuation at specific sites. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Radiation dose comparing standard PPE vs. Texray PPE groups
時間枠:Baseline, 4 and 8 weeks post-intervention
|
Radiation dose to the head and thyroid region (mSv), as measured by personal dosimeters during fluoroscopy-guided procedures, comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Role-specific radiation dose
時間枠:Baseline, 4 and 8 weeks post-intervention
|
Role-specific radiation dose in mSv will be measured (attending IR, trainee, technologist, nurse, anesthesia) comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
|
Procedure-specific radiation dose
時間枠:Baseline, 4 and 8 weeks post-intervention
|
Procedure-specific radiation dose in mSv (e.g., liver-directed therapy, embolization, venography, line and port placement) will be measured comparing standard PPE vs. Texray PPE groups.
|
Baseline, 4 and 8 weeks post-intervention
|
|
Radiation dose and attenuation stratified by fluoroscopy room
時間枠:Baseline, 4 and 8 weeks post-intervention
|
Radiation dose will be measured comparing standard PPE vs. Texray PPE groups stratified by fluoroscopy room and equipment age (new vs. legacy systems).
|
Baseline, 4 and 8 weeks post-intervention
|
|
Number of participants with correct donning/doffing placement of the PPE
時間枠:Baseline, 4 and 8 weeks post-intervention
|
Number of participants with correct PPE donning/doffing will be recorded.
|
Baseline, 4 and 8 weeks post-intervention
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Zachary Bercu, MD、Emory University
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- 2025P011985
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
IPD 共有時間枠
IPD 共有アクセス基準
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。